Try it
Pharmacology · Lipid drugs: lomitapide
Sample itemA young adult with homozygous familial hypercholesterolaemia and no functional LDL receptors does not respond adequately to statins. Which oral drug that inhibits microsomal triglyceride transfer protein may be used?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Lomitapide
Lomitapide inhibits MTP, reducing assembly and secretion of VLDL and chylomicrons and so lowering LDL independent of LDL receptors. It causes hepatic steatosis and gastrointestinal effects.
Option by option
A. Orlistat
Orlistat is a lipase inhibitor for obesity.
B. Lomitapide (correct)
Correct. MTP inhibition reduces lipoprotein assembly.
C. Ezetimibe
Ezetimibe acts on absorption and depends on LDL receptor-mediated clearance.
D. Niacin
Niacin lowers VLDL through different mechanisms and is not an MTP inhibitor.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?